1
|
Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling.
|
Clin Cancer Res
|
2005
|
4.84
|
2
|
Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKbeta.
|
Blood
|
2006
|
1.51
|
3
|
Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line is associated with cancer stem cell-like phenotype.
|
Int J Oncol
|
2011
|
0.96
|
4
|
IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis.
|
Arthritis Rheum
|
2006
|
0.96
|
5
|
Transactivation of the human NME5 gene by Sp1 in pancreatic cancer cells.
|
Gene
|
2012
|
0.82
|
6
|
Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells.
|
FEBS J
|
2012
|
0.78
|
7
|
Identification of cancer stem cells provides novel tumor models for drug discovery.
|
Front Med
|
2012
|
0.75
|
8
|
Novel anti-diabetic effect of SCM-198 via inhibiting the hepatic NF-κB pathway in db/db mice.
|
Biosci Rep
|
2012
|
0.75
|